Omer F. Bahcecioglu

The effect of G-CSF used after allogeneic hematopoietic stem cell transplantation on engraftment times and platelet suspension replacement numbers.

Journal: Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis

Published: January 02, 2022

Selection of the mobilization regimen in lymphoma patients: A retrospective cohort study.

Journal: Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis

Published: August 22, 2021

The effect of comorbidity on survival and collected CD34 + cell counts in autologous hematopoietic stem cell transplant patients.

Journal: Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis

Published: May 22, 2021

Filgrastim alone versus cyclophosphamide and filgrastim for mobilization in multiple myeloma patients.

Journal: Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis

Published: April 02, 2021

Is there any difference between busulfan-cyclophosphamide and cyclophosphamide-busulfan in patients underwent allogeneic transplantation?

Journal: Hematology, transfusion and cell therapy

Published: March 29, 2021

The safety profile of favipiravir in COVID-19 patients with severe renal impairment.

Journal: International journal of clinical practice

Published: March 14, 2021

Lenograstim versus filgrastim in mobilization before autologous hematopoietic stem cell transplantation in patients with multiple myeloma and lymphoma - Single center experience.

Journal: Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis

Published: February 16, 2021

The effect of G-CSF used after allogeneic hematopoietic stem cell transplantation on engraftment times and platelet suspension replacement numbers.

The effect of G-CSF used after allogeneic hematopoietic stem cell transplantation on engraftment times and platelet suspension replacement numbers.

Selection of the mobilization regimen in lymphoma patients: A retrospective cohort study.

Selection of the mobilization regimen in lymphoma patients: A retrospective cohort study.

The effect of comorbidity on survival and collected CD34 + cell counts in autologous hematopoietic stem cell transplant patients.

The effect of comorbidity on survival and collected CD34 + cell counts in autologous hematopoietic stem cell transplant patients.

Filgrastim alone versus cyclophosphamide and filgrastim for mobilization in multiple myeloma patients.

Filgrastim alone versus cyclophosphamide and filgrastim for mobilization in multiple myeloma patients.

Is there any difference between busulfan-cyclophosphamide and cyclophosphamide-busulfan in patients underwent allogeneic transplantation?

Is there any difference between busulfan-cyclophosphamide and cyclophosphamide-busulfan in patients underwent allogeneic transplantation?

The safety profile of favipiravir in COVID-19 patients with severe renal impairment.

The safety profile of favipiravir in COVID-19 patients with severe renal impairment.

Lenograstim versus filgrastim in mobilization before autologous hematopoietic stem cell transplantation in patients with multiple myeloma and lymphoma - Single center experience.

Lenograstim versus filgrastim in mobilization before autologous hematopoietic stem cell transplantation in patients with multiple myeloma and lymphoma - Single center experience.

Is sitagliptin effective for the treatment of COVID-19?

Is sitagliptin effective for the treatment of COVID-19?

Is it safe to use remdesivir in combination with a combined p-glycoprotein and CYP3A4 inhibitor?

Is it safe to use remdesivir in combination with a combined p-glycoprotein and CYP3A4 inhibitor?

Monoamine Oxidase-B (MAO-B) Inhibitors in the Treatment of Alzheimer's and Parkinson's Disease.

Monoamine Oxidase-B (MAO-B) Inhibitors in the Treatment of Alzheimer's and Parkinson's Disease.

Daptomycin in combination with rosuvastatin induced blood creatine phosphokinase elevation.

Daptomycin in combination with rosuvastatin induced blood creatine phosphokinase elevation.